Lay healthcare worker financial toxicity intervention: a pilot financial toxicity screening and referral program.

Cost of care Cost-effectiveness Financial toxicity Health services research Lay health worker

Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
16 Feb 2024
Historique:
received: 14 07 2023
accepted: 05 02 2024
medline: 19 2 2024
pubmed: 17 2 2024
entrez: 17 2 2024
Statut: epublish

Résumé

Financial toxicity is a source of significant distress for patients with urologic cancers, yet few studies have addressed financial burden in this patient population. We developed a financial toxicity screening program using a lay health worker (LHW) and social worker (SW) to assess and mitigate financial toxicity in a single academic medical clinic. As part of a quality improvement project, the LHW screened all newly diagnosed patients with advanced stages of prostate, kidney, or urothelial cancer for financial burden using three COST tool questions and referred patients who had significant financial burden to an SW who provided personalized recommendations. The primary outcome was feasibility defined as 80% of patients with financial burden completing the SW consult. Secondary outcomes were patient satisfaction, change in COST Tool responses, and qualitative assessment of financial resources utilized. The LHW screened a total of 185 patients for financial toxicity; 82% (n = 152) were male, 65% (n = 120) White, and 75% (n = 139) reported annual household income >$100,000 US Dollars; 60% (n = 114) had prostate cancer. A total of 18 (9.7%) participants screened positive for significant financial burden and were referred to the SW for consultation. All participants (100%) completed and reported satisfaction with the SW consultation and had 0.83 mean lower scores on the COST Tool post-intervention assessment compared to pre-intervention (95% confidence interval [0.26, 1.41]). This multidisciplinary financial toxicity intervention using an LHW and SW was feasible, acceptable, and associated with reduced financial burden among patients with advanced stages of urologic cancers. Future work should evaluate the effect of this intervention among cancer patients in diverse settings.

Identifiants

pubmed: 38366165
doi: 10.1007/s00520-024-08357-x
pii: 10.1007/s00520-024-08357-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

161

Informations de copyright

© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Références

Ting CY, Teh GC, Yu KL, Alias H, Tan HM, Wong LP (2020) Financial toxicity and its associations with health-related quality of life among urologic cancer patients in an upper middle-income country. Support Care Cancer. https://doi.org/10.1007/s00520-019-04975-y
Rotter J, Spencer JC, Wheeler SB (2019) Financial toxicity in advanced and metastatic cancer: overburdened and underprepared. J Oncol Pract 15(4):e300–e307. https://doi.org/10.1200/JOP.18.00518
doi: 10.1200/JOP.18.00518 pubmed: 30844331 pmcid: 6494243
Yabroff KR, Dowling EC, Guy GP et al (2016) Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol. https://doi.org/10.1200/JCO.2015.62.0468
Zafar SY, Peppercorn JM, Schrag D et al (2013) The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist. https://doi.org/10.1634/theoncologist.2012-0279
Ramsey SD, Bansal A, Fedorenko CR et al (2016) Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. https://doi.org/10.1200/JCO.2015.64.6620
Bestvina CM, Zullig LL, Rushing C et al (2014) Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract. https://doi.org/10.1200/JOP.2014.001406
Meropol NJ, Schrag D, Smith TJ et al (2009) American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. https://doi.org/10.1200/JCO.2009.23.1183
Fischer KA, Walling A, Wenger N, Glaspy J (2020) Cost health literacy as a physician skill-set: the relationship between oncologist reported knowledge and engagement with patients on financial toxicity. Support Care Cancer. https://doi.org/10.1007/s00520-020-05406-z
Ragavan M, Parikh D, Patel M (2021) Defining the clinician’s role in mitigating financial toxicity: an exploratory study. Support Care Cancer. https://doi.org/10.1007/s00520-021-05984-6
Tarnasky AM, Tran GN, Nicolla J et al (2021) Mobile application to identify cancer treatment–related financial assistance: results of a randomized controlled trial. JCO Oncol Pract 17:e1440–e1449. https://doi.org/10.1200/OP.20.00757
doi: 10.1200/OP.20.00757 pubmed: 33797952 pmcid: 8791821
Raghavan D, Keith NA, Warden HR et al (2021) Levine Cancer Institute Financial Toxicity Tumor Board: a potential solution to an emerging problem. JCO Oncol Pract 17:e1433–e1439
doi: 10.1200/OP.21.00124 pubmed: 34101495 pmcid: 8791826
Monak M, Bell K, Whitt A (2019) Development of a financial navigation program to ease the burden of financial toxicity. J Clin Oncol 37(15_suppl):6565. https://doi.org/10.1200/JCO.2019.37.15_suppl.6565
doi: 10.1200/JCO.2019.37.15_suppl.6565
Yezefski T, Steelquist J, Watabayashi K, Sherman D, Shankaran V (2018) Impact of trained oncology financial navigators on patient out-of-pocket spending. Am J Manag Care 24:S74–S79
Haverfield MC, Singer AE, Gray C, Shelley A, Nash A, Lorenz KA (2020) Implementing routine communication about costs of cancer treatment: perspectives of providers, patients, and caregivers. Support Care Cancer. https://doi.org/10.1007/s00520-019-05274-2
Freeman HP (2013) The history, principles, and future of patient navigation: commentary. Semin Oncol Nurs. https://doi.org/10.1016/j.soncn.2013.02.002
Fouad M, Wynn T, Martin M, Partridge E (2010) Patient navigation pilot project: results from the Community Health Advisors in Action Program (CHAAP). Ethn Dis 20(2):155–161
Fouad MN, Johnson RE, Nagy MC, Person SD, Partridge EE (2014) Adherence and retention in clinical trials: a community-based approach. Cancer. https://doi.org/10.1002/cncr.28572
Patel MI, Kapphahn K, Dewland M, Aguilar V, Sanchez B, Sisay E, Murillo A, Smith K, Park DJ (2022) Effect of a community health worker intervention on acute care use, advance care planning, and patient-reported outcomes among adults with advanced stages of cancer: a randomized clinical trial. JAMA Oncol 8(8):1139–1148. https://doi.org/10.1001/jamaoncol.2022.1997
Patel MI, Ramirez D, Agajanian R, Agajanian H, Coker T (2020) Association of a lay health worker intervention with symptom burden, survival, health care use, and total costs among medicare enrollees with cancer. JAMA Netw Open 3(3):e201023. https://doi.org/10.1001/jamanetworkopen.2020.1023
doi: 10.1001/jamanetworkopen.2020.1023 pubmed: 32176306 pmcid: 7076340
Patel MI, Sundaram V, Desai M, Periyakoil VS, Kahn JS, Bhattacharya J et al (2018) Effect of a lay health worker intervention on goals-of-care documentation and on health care use, costs, and satisfaction among patients with cancer: a randomized clinical trial. JAMA Oncol 4(10):1359–1366. https://doi.org/10.1001/jamaoncol.2018.2446
doi: 10.1001/jamaoncol.2018.2446 pubmed: 30054634 pmcid: 6233780
de Souza JA, Yap BJ, Wroblewski K et al (2017) Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer 123(3):476–484. https://doi.org/10.1002/cncr.30369
doi: 10.1002/cncr.30369 pubmed: 27716900
Parikh DA, Ragavan M, Dutta R et al (2021) Financial toxicity of cancer care: an analysis of financial burden in three distinct health care systems. JCO Oncol Pract:OP2000890. https://doi.org/10.1200/OP.20.00890
Yabroff KR, Bradley C, Shih YCT (2020) Understanding financial hardship among cancer survivors in the United States: strategies for prevention and mitigation. J Clin Oncol. 38:292–301
doi: 10.1200/JCO.19.01564 pubmed: 31804869
Khera N, Sugalski J, Krause D, Butterfield R, Zhang N, Stewart FM, Carlson RW, Griffin JM, Zafar SY, Lee SJ (2020) Current practices for screening and management of financial distress at NCCN member institutions. J Natl Compr Canc Netw 18(7):825–831. https://doi.org/10.6004/jnccn.2020.7538
Shankaran V, Leahy T, Steelquist J, Watabayashi K, Linden H, Ramsey S, Schwartz N, Kreizenbeck K, Nelson J, Balch A, Singleton E, Gallagher K, Overstreet K (2018) Pilot feasibility study of an oncology financial navigation program. J Oncol Pract 14(2):e122–e129. https://doi.org/10.1200/JOP.2017.024927
doi: 10.1200/JOP.2017.024927 pubmed: 29272200
Smith GL, Banegas MP, Acquati C, Chang S, Chino F, Conti RM et al (2022) Navigating financial toxicity in patients with cancer: a multidisciplinary management approach. CA Cancer J Clin 72(5):437–453. https://doi.org/10.3322/caac.21730
doi: 10.3322/caac.21730 pubmed: 35584404
Han X, Zhao J, Zheng Z, de Moor JS, Virgo KS, Yabroff KR (2020) Medical financial hardship intensity and financial sacrifice associated with cancer in the United States. Cancer Epidemiol Biomarkers Prev 29:308–317
doi: 10.1158/1055-9965.EPI-19-0460 pubmed: 31941708 pmcid: 7007367
Esselen KM, Gompers A, Hacker MR et al (2021) Evaluating meaningful levels of financial toxicity in gynecologic cancers. Int J Gynecol Cancer 31:801–806
doi: 10.1136/ijgc-2021-002475 pubmed: 33858954 pmcid: 9728957
Smith GL, Lopez-Olivo MA, Advani PG et al (2019) Financial burdens of cancer treatment: a systematic review of risk factors and outcomes. J Natl Compr Canc Netw 17:1184–1192
doi: 10.6004/jnccn.2019.7305 pubmed: 31590147 pmcid: 7370695
Benedict C, Fisher S, Schapira L et al (2022) Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors. Psychooncology 31(1):9–20. https://doi.org/10.1002/pon.5763
doi: 10.1002/pon.5763 pubmed: 34224603
Madore S, Kilbourn K, Valverde P, Borrayo E, Raich P (2014) Feasibility of a psychosocial and patient navigation intervention to improve access to treatment among underserved breast cancer patients. Supportive Care Cancer 22(8):2085–2093. https://doi.org/10.1007/s00520-014-2176-5
doi: 10.1007/s00520-014-2176-5
Sadigh G, Gallagher K, Obenchain J, Benson A, Mitchell E, Sengupta S, Carlos RC (2019) Pilot feasibility study of an oncology financial navigation program in brain cancer patients. J Am Coll Radiol 16(10):1420–1424. https://doi.org/10.1016/j.jacr.2019.07.014
doi: 10.1016/j.jacr.2019.07.014 pubmed: 31585660 pmcid: 6779332
Watabayashi K, Steelquist J, Overstreet KA, Leahy A, Bradshaw E, Gallagher KD et al (2020) A pilot study of a comprehensive financial navigation program in patients with cancer and caregivers. J Natl Compr Canc Netw 18(10):1366–1373. https://doi.org/10.6004/jnccn.2020.7581
doi: 10.6004/jnccn.2020.7581 pubmed: 33022646
Wheeler S, Rodriguez-O'Donnell J, Rogers C, Fulcher J, Deal A, Manning M et al (2020) Reducing cancer-related financial toxicity through financial navigation: results from a pilot intervention. Cancer Epidemiol Biomarkers Prev 29(3):694. https://doi.org/10.1158/1055-9965.EPI-20-0067
doi: 10.1158/1055-9965.EPI-20-0067
Khera N, Zhang N, Hilal T et al (2022) Association of health insurance literacy with financial hardship in patients with cancer. JAMA Netw Open 5(7):e2223141. https://doi.org/10.1001/jamanetworkopen.2022.23141
doi: 10.1001/jamanetworkopen.2022.23141 pubmed: 35877122 pmcid: 9315419

Auteurs

Divya A Parikh (DA)

Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA. divyaa@stanford.edu.
Medical Services, VA Palo Alto Health Care System, Palo Alto, CA, USA. divyaa@stanford.edu.

Gladys M Rodriguez (GM)

Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA.

Meera Ragavan (M)

Kaiser Permanente Division of Research, Oakland, CA, USA.

Elizabeth Kerr (E)

Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA.

Mary Khay Asuncion (MK)

Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA.

Jennifer Hansen (J)

Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA.

Sandy Srinivas (S)

Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA.

Alice C Fan (AC)

Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA.

Sumit Shah (S)

Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA.

Manali I Patel (MI)

Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA.
Medical Services, VA Palo Alto Health Care System, Palo Alto, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH